Drawing for HEALTHBERRY

USPTO serial 79190355

HEALTHBERRY

Reviewed by CopyMark Law Group

Reg. 6578271Status 700Renewal
Filing date
Status date
Registration date
Dec 7, 2021
Examiner
LAM, HAI-LY HUYNH
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with HEALTHBERRY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Scott D. Woldow

Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP1055 Thomas Jefferson St. NW, Suite 400WASHINGTON, DC 20007UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and veterinary preparations for the treatment of nutrition deficiencies and disorders; medical and veterinary preparations for the treatment of nutrition diseases and nutrition deficiencies; medical and veterinary preparations and articles, namely, amino acids for medical or veterinary purposes; chemical preparations for medical, pharmaceutical and veterinary purposes for the treatment of nutrition deficiencies; amino acids for medical and veterinary purposes; cellulose esters and medicinal oils all for medical and veterinary purposes; salts, in particular potassium and sodium salts for medical purposes; steroids; biological preparations for medical and veterinary purposes, namely, for the treatment of nutrition disorders and cancer; ferments for pharmaceutical purposes, yeast for pharmaceutical purposes; starch for pharmaceutical purposes; enzymes and enzyme preparations for medical and veterinary purposes; bacteriological preparations for medical and veterinary use; sanitary preparations for medical purposes; foodstuffs and dietetic substances, namely, pasta and sugar all adapted for medical or veterinary purposes; dietetic foods, namely, crackers and bread all adapted for medical use, albuminous preparations for medical purposes, namely, albumin dietary supplements; medicated candy and dietetic beverages adapted for medicinal purposes; dietetic beverages adapted for medical purposes, namely, medicinal drinks, nutritionally fortified beverages for medical purposes; dietetic substances, namely, sugar substitutes all adapted for medical use, medical preparations for slimming purposes; infant formula; dietary supplements for humans; dietary supplements for animals; dietary supplements and dietetic preparations, namely, vitamin preparations, multi-vitamin preparations; sugar, in particular candy and glucose for medical purposes; glucose for medical purposes; albuminous foodstuffs, namely, medicated supplements containing albumin for foodstuffs for babies; protein dietary supplements; dietary fiber for aiding in digestion and treating constipation; mineral food supplements; preparations of trace elements, namely, mineral supplements, vitamin supplements for human and animal use, vitamin preparations; dietary food supplements, food supplements, and health food supplements derived from bilberry and blackcurrant; antioxidant enriched nutritional supplements; dietary and nutritional supplements for improving heart health and lowering the risk of developing diabetes; dietary and nutritional supplements for strengthening visual acuity; pharmaceutical and veterinary preparations for the treatment of atherosclerosis, hypertension, hyperlipidemia, inflammation, and oxidative stress; pharmaceutical and veterinary preparations for lowering cholesterol; pharmaceutical and veterinary preparations for the treatment of cardiovascular disease and promoting heart health; pharmaceutical and veterinary preparations to reduce fat accumulation in visceral areas and liver tissue; pharmaceutical and veterinary preparations for the treatment of cancer; pharmaceutical and veterinary preparations for eye health; nutraceuticals for use as a dietary supplementACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 22, 2026RNWLINTERNATIONAL REGISTRATION RENEWED—
Aug 1, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 11, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 6, 2023BDFUBIRTH/DEATH MERGER PROCESSED BY USPTO—
Jul 4, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 23, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 23, 2022FIMPFINAL DISPOSITION PROCESSED—
Mar 7, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 7, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 3, 2021GPNXNOTIFICATION PROCESSED BY IB—
Sep 21, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 21, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 1, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 1, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Sep 1, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 19, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 18, 2021RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jun 26, 2021LIENAPPLICANT AMENDMENT REQUIRES LAW OFFICE ENTRY—
Nov 24, 2020RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Apr 28, 2020RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Oct 17, 2019DCPNCHANGE OF OWNER RECEIVED FROM IB—
Oct 15, 2019RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Mar 28, 2019RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Mar 25, 2019ALIEASSIGNED TO LIE—
Sep 8, 2018RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Sep 8, 2018ALIEASSIGNED TO LIE—
Mar 6, 2018RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Feb 9, 2018OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jan 24, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 24, 2018OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Sep 3, 2017GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Sep 3, 2017GNSLLETTER OF SUSPENSION E-MAILED—
Sep 3, 2017CNSLSUSPENSION LETTER WRITTEN—
Aug 16, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 16, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 15, 2017ALIEASSIGNED TO LIE—
Jul 24, 2017ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Mar 21, 2017GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 21, 2017GNSLLETTER OF SUSPENSION E-MAILED—
Mar 21, 2017CNSLSUSPENSION LETTER WRITTEN—
Feb 28, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 27, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 27, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 16, 2016RFNTREFUSAL PROCESSED BY IB—
Aug 26, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 26, 2016RFRRREFUSAL PROCESSED BY MPU—
Aug 26, 2016RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 25, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 23, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 19, 2016DOCKASSIGNED TO EXAMINER—
Aug 19, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 18, 2016REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance